Dr Julie Thoms is a Senior Research Fellow in the Adult Cancer Program and School of Biomedical Sciences. Her research interests lie in understanding how gene regulatory networks control stem cell characteristics during normal and leukemic blood development, with the ultimate aim of using this knowledge to develop targeted therapies for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).

Keywords: transcription factor, histone modification, enhancer, chromatin, blood cancer, hematopoiesis, leukaemia, genomics, epigenetics